Results
|
|
101.
|
|
|
|
102.
|
The effect of novel therapies in high-molecular-risk multiple myeloma. [electronic resource] by
- Lancman, Guido
- Tremblay, Douglas
- Barley, Kevin
- Barlogie, Bart
- Cho, Hearn Jay
- Jagannath, Sundar
- Madduri, Deepu
- Moshier, Erin
- Parekh, Samir
- Chari, Ajai
Producer: 20180723
In:
Clinical advances in hematology & oncology : H&O vol. 15
Availability: No items available.
|
|
|
103.
|
|
|
|
104.
|
|
|
|
105.
|
|
|
|
106.
|
|
|
|
107.
|
|
|
|
108.
|
|
|
|
109.
|
Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma. [electronic resource] by
- Richardson, Paul G
- Laubach, Jacob P
- Lonial, Sagar
- Moreau, Philippe
- Yoon, Sung-Soo
- Hungria, Vânia T M
- Dimopoulos, Meletios A
- Beksac, Meral
- Alsina, Melissa
- San-Miguel, Jesús F
Producer: 20160428
In:
Expert review of anticancer therapy vol. 15
Availability: No items available.
|
|
|
110.
|
|
|
|
111.
|
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function. [electronic resource] by
- Wong, Deborah J L
- Rao, Amol
- Avramis, Earl
- Matsunaga, Douglas R
- Komatsubara, Kimberly M
- Atefi, Mohammad S
- Escuin-Ordinas, Helena
- Chodon, Thinle
- Koya, Richard C
- Ribas, Antoni
- Comin-Anduix, Begoña
Producer: 20141228
In:
Cancer immunology research vol. 2
Availability: No items available.
|
|
|
112.
|
|
|
|
113.
|
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma. [electronic resource] by
- Maly, Joseph J
- Christian, Beth A
- Zhu, Xiaohua
- Wei, Lai
- Sexton, Jennifer L
- Jaglowski, Samantha M
- Devine, Steven M
- Fehniger, Todd A
- Wagner-Johnston, Nina D
- Phelps, Mitch A
- Bartlett, Nancy L
- Blum, Kristie A
Producer: 20180319
In:
Clinical lymphoma, myeloma & leukemia vol. 17
Availability: No items available.
|
|
|
114.
|
|
|
|
115.
|
|
|
|
116.
|
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity. [electronic resource] by
- Li, Xiaoyang
- Jiang, Yuqi
- Peterson, Yuri K
- Xu, Tongqiang
- Himes, Richard A
- Luo, Xin
- Yin, Guilin
- Inks, Elizabeth S
- Dolloff, Nathan
- Halene, Stephanie
- Chan, Sherine S L
- Chou, C James
Producer: 20201023
In:
Journal of medicinal chemistry vol. 63
Availability: No items available.
|
|
|
117.
|
|
|
|
118.
|
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study. [electronic resource] by
- Kaufman, Jonathan L
- Mina, Roberto
- Jakubowiak, Andrzej J
- Zimmerman, Todd L
- Wolf, Jeffrey J
- Lewis, Colleen
- Gleason, Charise
- Sharp, Cathy
- Martin, Thomas
- Heffner, Leonard T
- Nooka, Ajay K
- Harvey, R Donald
- Lonial, Sagar
Producer: 20190425
In:
Blood cancer journal vol. 9
Availability: No items available.
|
|
|
119.
|
|
|
|
120.
|
Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome. [electronic resource] by
- Dimicoli, Sophie
- Jabbour, Elias
- Borthakur, Gautam
- Kadia, Tapan
- Estrov, Zeev
- Yang, Hui
- Kelly, Mary
- Pierce, Sherry
- Kantarjian, Hagop
- Garcia-Manero, Guillermo
Producer: 20120504
In:
American journal of hematology vol. 87
Availability: No items available.
|